Rate and energy headlines have kept the broad market jumpy, yet one sector keeps finding buyers. Healthcare has led on days when the S&P 500 slipped, and the Nasdaq Biotechnology Index has pushed to record highs.
The money isn’t chasing one drug. It’s following a shift in where artificial intelligence (AI) is pointed. Chips, code and business data defined the first waves of the AI trade. The next target is the human body, a data set with 8 billion members.
